Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019

BUY
$5.66 - $7.89 $904,366 - $1.26 Million
159,782 New
159,782 $959,000
Q4 2018

Feb 15, 2019

SELL
$4.77 - $7.9 $2.88 Million - $4.76 Million
-602,886 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$6.03 - $8.34 $3.18 Million - $4.4 Million
527,886 Added 703.85%
602,886 $4.16 Million
Q2 2018

Aug 14, 2018

BUY
$5.89 - $7.29 $441,750 - $546,750
75,000 New
75,000 $446,000

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $439M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track Howard Marks's Portfolio

Track Howard Marks Portfolio

Follow Howard Marks (Oaktree Capital Management LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oaktree Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Oaktree Capital Management LP and Howard Marks with notifications on news.